These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36831610)

  • 1. Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.
    Lhermitte B; Wolf T; Chenard MP; Coca A; Todeschi J; Proust F; Hirsch E; Schott R; Noel G; Guerin E; Reita D; Chammas A; Salmon A; Martin S; Dontenwill M; Entz-Werlé N
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution.
    Di Nunno V; Gatto L; Tosoni A; Bartolini S; Franceschi E
    Front Oncol; 2022; 12():1067252. PubMed ID: 36686797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas.
    Penman CL; Faulkner C; Lowis SP; Kurian KM
    Front Oncol; 2015; 5():54. PubMed ID: 25785246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies.
    Tan JY; Wijesinghe IVS; Alfarizal Kamarudin MN; Parhar I
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.
    Dasgupta T; Haas-Kogan DA
    Front Oncol; 2013; 3():110. PubMed ID: 23717811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.
    Ali RH; Almanabri M; Ali NY; Alsaber AR; Khalifa NM; Hussein R; Alateeqi M; Mohammed EMA; Jama H; Almarzooq A; Benobaid N; Alqallaf Z; Ahmed AA; Bahzad S; Almurshed M
    J Clin Pathol; 2024 Jan; ():. PubMed ID: 38195220
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Talloa D; Triarico S; Agresti P; Mastrangelo S; Attinà G; Romano A; Maurizi P; Ruggiero A
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077798
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
    Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
    Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
    Nobre L; Zapotocky M; Ramaswamy V; Ryall S; Bennett J; Alderete D; Balaguer Guill J; Baroni L; Bartels U; Bavle A; Bornhorst M; Boue DR; Canete A; Chintagumpala M; Coven SL; Cruz O; Dahiya S; Dirks P; Dunkel IJ; Eisenstat D; Faure Conter C; Finch E; Finlay JL; Frappaz D; Garre ML; Gauvain K; Bechensteen AG; Hansford JR; Harting I; Hauser P; Hazrati LN; Huang A; Injac SG; Iurilli V; Karajannis M; Kaur G; Kyncl M; Krskova L; Laperriere N; Larouche V; Lassaletta A; Leary S; Lin F; Mascelli S; McKeown T; Milde T; Morales La Madrid A; Morana G; Morse H; Mushtaq N; Osorio DS; Packer R; Pavelka Z; Quiroga-Cantero E; Rutka J; Sabel M; Salgado D; Solano P; Sterba J; Su J; Sumerauer D; Taylor MD; Toledano H; Tsang DS; Valente Fernandes M; van Landeghem F; van Tilburg CM; Wilson B; Witt O; Zamecnik J; Bouffet E; Hawkins C; Tabori U
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained response of three pediatric BRAF
    Toll SA; Tran HN; Cotter J; Judkins AR; Tamrazi B; Biegel JA; Dhall G; Robison NJ; Waters K; Patel P; Cooper R; Margol AS
    Oncotarget; 2019 Jan; 10(4):551-557. PubMed ID: 30728904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in
    Usta D; Sigaud R; Buhl JL; Selt F; Marquardt V; Pauck D; Jansen J; Pusch S; Ecker J; Hielscher T; Vollmer J; Sommerkamp AC; Rubner T; Hargrave D; van Tilburg CM; Pfister SM; Jones DTW; Remke M; Brummer T; Witt O; Milde T
    Mol Cancer Ther; 2020 Aug; 19(8):1736-1750. PubMed ID: 32451331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated molecular and clinical analysis of BRAF-mutant glioma in adults.
    Schreck KC; Langat P; Bhave VM; Li T; Woodward E; Pratilas CA; Eberhart CG; Bi WL
    NPJ Precis Oncol; 2023 Feb; 7(1):23. PubMed ID: 36854806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
    J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
    Olow A; Mueller S; Yang X; Hashizume R; Meyerowitz J; Weiss W; Resnick AC; Waanders AJ; Stalpers LJ; Berger MS; Gupta N; James CD; Petritsch CK; Haas-Kogan DA
    Clin Cancer Res; 2016 Nov; 22(21):5312-5321. PubMed ID: 27217440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
    Dasgupta T; Olow AK; Yang X; Hashizume R; Nicolaides TP; Tom M; Aoki Y; Berger MS; Weiss WA; Stalpers LJ; Prados M; James CD; Mueller S; Haas-Kogan DA
    J Neurooncol; 2016 Feb; 126(3):385-93. PubMed ID: 26384810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric low-grade gliomas can be molecularly stratified for risk.
    Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
    Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successes and challenges in modeling heterogeneous BRAF
    Xing YL; Panovska D; Petritsch CK
    Front Oncol; 2023; 13():1223199. PubMed ID: 37920169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
    Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.
    Horbinski C; Nikiforova MN; Hagenkord JM; Hamilton RL; Pollack IF
    Neuro Oncol; 2012 Jun; 14(6):777-89. PubMed ID: 22492957
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Del Bufalo F; Ceglie G; Cacchione A; Alessi I; Colafati GS; Carai A; Diomedi-Camassei F; De Billy E; Agolini E; Mastronuzzi A; Locatelli F
    Front Oncol; 2018; 8():526. PubMed ID: 30488019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.